216 related articles for article (PubMed ID: 2507263)
1. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis.
Alberti A; Chemello L; Fattovich G; Pontisso P; Semenzato G; Colletta C; Vinante F; Pizzolo G
Dig Dis Sci; 1989 Oct; 34(10):1559-63. PubMed ID: 2507263
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc.
Xiao P; Chen QF; Yang YL; Guo ZH; Chen H
World J Gastroenterol; 2006 Jan; 12(3):482-4. PubMed ID: 16489655
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble Tac peptide in acute and chronic hepatitis B virus infection.
Chu CM; Liaw YF
Clin Immunol Immunopathol; 1989 Oct; 53(1):52-8. PubMed ID: 2788545
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases.
Monsalve-De Castillo F; Romero TA; Estévez J; Costa LL; Atencio R; Porto L; Callejas D
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1372-5. PubMed ID: 12414777
[TBL] [Abstract][Full Text] [Related]
6. Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Yamaguchi S; Onji M; Ohta Y
Hepatogastroenterology; 1988 Oct; 35(5):245-8. PubMed ID: 3068111
[TBL] [Abstract][Full Text] [Related]
7. Serum binding activity for polymerized human albumin due to antibodies detected by enzyme-linked immunosorbent assay in acute and chronic type B, A and NANB viral hepatitis.
Baraldini M; Miglio F; Cursaro C; Stefanini GF; Micaletti E; Pontisso P; Alberti A; Gasbarrini G
Ric Clin Lab; 1987; 17(2):131-42. PubMed ID: 3114866
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.
Leung NW; Leung JC; Tam JS; Lau JT; Lai KN
Am J Gastroenterol; 1992 Jan; 87(1):113-7. PubMed ID: 1728107
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group.
Naveau S; Balian A; Degos F; Daurat V; Chevret S; Gayno S; Bastie A; Riachi G; Bartolomei-Portal I; Barange K; Moussalli J; Bailly F; Chaumet-Riffaud P; Emilie D
J Hepatol; 1999 Oct; 31(4):612-7. PubMed ID: 10551383
[TBL] [Abstract][Full Text] [Related]
12. Viral markers of hepatitis.
Velasco M
Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
[No Abstract] [Full Text] [Related]
13. Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?
Lai KN; Lai FM; Leung NW; Lo ST; Tam JS
Am J Clin Pathol; 1990 Jan; 93(1):79-83. PubMed ID: 2104740
[TBL] [Abstract][Full Text] [Related]
14. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B].
Pawłowska M; Halota W; Smukalska E; Grabczewska E
Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.
Davis GL; Hoofnagle JH
Ann Intern Med; 1985 Jun; 102(6):762-5. PubMed ID: 3994187
[TBL] [Abstract][Full Text] [Related]
16. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
18. In subjects with antibody to hepatitis C virus a high serum level of interleukin-2 soluble receptor suggests activity of liver disease.
Gessoni G; Valverde S; Giacomini A; Antico F; Manoni F
J Viral Hepat; 1998 Mar; 5(2):99-103. PubMed ID: 9572034
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
Horiike N; Blumberg BS; Feitelson MA
J Infect Dis; 1991 Dec; 164(6):1104-12. PubMed ID: 1955710
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.
Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Ohmiya M; Tani Y; Ikematsu H; Kashiwagi S
Dig Dis Sci; 1995 Aug; 40(8):1837-41. PubMed ID: 7648988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]